Strattera (atomoxetine) is an antipsychotic medication that belongs to the class of, or. It is an atypical antipsychotic that works by blocking the reuptake of certain chemicals in the brain. Strattera works by altering the balance of chemicals in the brain, which can help to fight mental illnesses such as ADHD.
Strattera is a selective reuptake inhibitor (SSRI) that works by blocking the reabsorption of serotonin in the brain. Serotonin is a neurotransmitter that plays a significant role in mood, attention, and behavior. By blocking its reuptake, Strattera prevents the reabsorption of serotonin in the brain, thus improving mood and attention.
Strattera can cause side effects such as:
If you experience any of these side effects, talk to your doctor or pharmacist immediately.
Strattera is a prescription medication for ADHD that works by boosting the levels of dopamine and norepinephrine in the brain. This helps to boost the activity of the dopamine-reuptake inhibitor (DRIs) dopamine and norepinephrine reuptake. By reducing dopamine and norepinephrine reuptake, Strattera can help improve attention and mood in individuals with ADHD.
Strattera works by increasing the levels of norepinephrine in the brain, which helps to regulate mood and reduce irritability. By increasing norepinephrine levels, Strattera can help regulate mood and reduce irritability in individuals with ADHD.
Strattera helps in managing symptoms of ADHD. It is not an ADHD medication but it works by inhibiting the reuptake of dopamine and norepinephrine in the brain. This means that Strattera may help to improve mood and reduce irritability.
Strattera is not an ADHD medication but it works by increasing the levels of norepinephrine in the brain. This can be a symptom of ADHD. By increasing the levels of norepinephrine, Strattera may help to improve attention, reduce irritability, and reduce symptoms of ADHD.
Strattera is a prescription medication that is used to treat ADHD. It works by increasing the levels of norepinephrine, which helps to regulate mood and reduce irritability. Strattera also helps to improve attention and reduce symptoms of ADHD. This may be beneficial for individuals with ADHD.
Strattera is a prescription medication that works by increasing the levels of norepinephrine in the brain, which helps to regulate mood and reduce irritability.
This may be a symptom of ADHD.
Salt Composition in both
Salt Composition
Atomoxetine 20mg(same for both)
You Searched
Strip of 10 tablets
We only sell the best substitute from top brands
Our Recommendation
Flupentixine 20mg Tablet 10s
2,022+ Customers trust this
WHO GMP Certified
Marketed by
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
Must be:1*isalikeney
Ufrirods 10mg Tablet 10sUleator 10mg Tablet 10sCipcal D3 60000IU Capsule 3sApellica 10mg Tablet 10sBayer 10mg Tablet 10s
1*SERife
Forumhatted by volunteeraping the medical profession:)"Patients prescribed medication for attention deficit hyperactivity disorder may be prescribed medication for depression, while those prescribed medication for Attention Deficit Hyperactivity Disorder may be prescribed medication for an as-needed basis."View More
The Havelockautions and Warnings (HAP) Act would require the use of antidepressant medications in patients with a history of at least six months of treatment with antidepressants. The medication should not be given to a patient with an antidepressant within five days of starting treatment.
Struggling with attention deficit disorder (ADHD) can cause feelings of drowsiness, impaired concentration, and difficulty concentrating. ADHD is a neurodevelopmental disorder that affects the brain and affected individuals may experience difficulties in understanding, remembering, and self-administration of reality. ADHD affects a significant portion of the U. S. population with a prevalence of 1 in 4,000 people affected. ADHD is defined by the Centers for Disease Control and Prevention as being the inability to get or maintain an adequate level of attention and sustaining an ability to concentrate on tasks and/or perform tasks for which there is insufficient benefit. ADHD is also defined as an individual’s inability to focus on or process important information effectively and efficiently. ADHD is a mental health condition that affects nearly every age group. ADHD can have various causes, including a diagnosis that is based on certain medical conditions, psychological disorders, or other neurological disorders. ADHD can also have psychological and physical consequences that affect the quality of life of individuals. People who are diagnosed with ADHD may be more prone to develop comorbidities that impact their quality of life.
Struggling with ADHDADHD can have various symptoms, including:
These symptoms can be caused by several factors that affect ADHD. Some of the key factors that can lead to ADHD are:
In addition to mental health disorders, ADHD can also cause physical symptoms, including:
People who experience these symptoms of ADHD may also be diagnosed with physical symptoms. Physical symptoms of ADHD include:
In addition to mental health disorders, ADHD can also cause psychological symptoms:
Some of the physical symptoms of ADHD may cause psychological symptoms.
ADHD can also cause physical symptoms of physical symptoms.
Psychological symptoms of ADHD may also cause psychological symptoms.
Other psychological symptoms of ADHD may also cause physical symptoms.
ADHD can also cause psychological symptoms.
A recent study byeHealthOnefound that nearly one-third of adults ages 16 to 44 experience some degree of anxiety or depression.
In this study, researchers from The University of Texas Southwestern Medical Center, sponsored by TUSWEST, analyzed data from more than 600,000 adults in the United States, as well as from more than 400,000 non-high-income countries, about 10 million people in Africa, the Middle East and Southeast Asia, Asia Pacific and Latin America.
In the study, the researchers compared the rates of anxiety and depression associated with the use of Strattera — a medication for ADHD — to those of the placebo. The results showed that those who took Strattera were more likely to experience at least one of the symptoms of anxiety and depression.
“The research suggests that the most common reasons for the anxiety and depression associated with ADHD are the physical conditions and relationship issues,” said lead researcher Dr. Sarah Thompson, an assistant professor in the department of psychiatry at the University of Virginia and director of the Center for Behavioral Medicine and Psychiatry. “These are the factors that are often the most significant for the anxiety and depression symptoms.”
The study found that, compared to the placebo group, adults who took Strattera also had about a four-fold higher rate of anxiety than the other groups.
“It is important to note that this is the first study to investigate the impact of medication on anxiety and depression symptoms,” said Dr. Susan Greenblatt, a professor of psychiatry and family medicine at the University of California, San Francisco. “This provides a new window into the relationship between medication and anxiety.”
Dr. Jonathan Schondelmeyer, director of behavioral medicine and the researcher, said the findings have important implications for researchers studying the connection between the medications and anxiety and depression.
“We see a need for more studies to evaluate the impact of medication on anxiety and depression,” said Schondelmeyer.
The U. S. Food and Drug Administration (FDA) approved Strattera (atomoxetine) in 2015 for the treatment of ADHD in children, adolescents and adults. This approval sparked a national lobbying campaign to expand access to this medication.
In 2015, the FDA approved atomoxetine for the treatment of ADHD in adults, adolescents and children aged 12 and older. In 2017, the agency approved Strattera for the treatment of ADHD in adults, adolescents and children aged 12 and older.
While it is unknown how Strattera affected anxiety or depression, previous research has shown that there is no increased risk of suicidal thoughts or behaviors in individuals taking the medication.
In the study, the researchers found that those who took Strattera were more likely to experience at least one of the symptoms of anxiety and depression.
“We found that compared to the placebo group, the patients who took Strattera had a four-fold higher rate of anxiety than the placebo group,” said Thompson. “This finding suggests that the medication may have more impact on the development of depression in the brain.”
Thompson added that the researchers are currently investigating the long-term effects of Strattera on depression. She said she was surprised the findings were published but that it would be too soon to say for sure.
“I want to make sure it’s done,” she said.
Thompson noted that this is the first study to demonstrate that Strattera can have a positive effect on depression.
“The research is important because it suggests there is a relationship between medication and anxiety,” she said. “This suggests that we may be able to explore these potential mechanisms in the future.”
Sarah Giddens, a researcher at the University of California, San Francisco, said that this study was particularly important because it is important to understand why some people may be more likely to have anxiety or depression. “In this study, we found that the most common reasons for anxiety and depression were the physical conditions,” she said.
“This is the first study to investigate the impact of medication on anxiety and depression,” said Schondelmeyer.
“This provides a new window into the relationship between medication and anxiety,” Thompson said. “This provides a new window into the relationship between the medication and anxiety, and it will take many years before we can really determine why the anxiety or depression is occurring in the brain.”
Thompson said the study provides the first step in understanding the connection between anxiety and depression.
Alternate Name:Bupropion
Description:Atomoxetine is a selective norepinephrine reuptake inhibitor (SNRI). Bupropion is commonly known by the brand name "Alternate Name" before the generic alternative is listed first. The generic alternative is listed last. The list includes the following fivenihas:
Dosage Form:oral tablet
Administration Route:By mouth
Drug Class:Norepinephrine reuptake inhibitor (SSRI)
DrugBrand:
Generic:D34
GenericDate for First Use:Form
FDA Approval:G252280 (i.e., FDA-approved generic alternative to atomoxetine [US FDA-approved generic alternative]).
GenericBrand:
okinetic:Time to onset of effects
Mechanism of Action:Bupropion hinders norepinephrine reuptake in the brain by inhibiting this enzyme.
Stade de France Pharmacy